| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
OptiNose Inc (NASDAQ: OPTN)
OPTN Technical Analysis
5
| As on 9th Jun 2023 OPTN STOCK Price closed @ 1.24 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.82 & Strong Sell for SHORT-TERM with Stoploss of 2.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OPTNSTOCK Price
| Open | 1.19 | Change | Price | % |
| High | 1.29 | 1 Day | 0.06 | 5.08 |
| Low | 1.18 | 1 Week | -0.01 | -0.80 |
| Close | 1.24 | 1 Month | -0.55 | -30.73 |
| Volume | 727384 | 1 Year | -0.43 | -25.75 |
| 52 Week High 4.02 | 52 Week Low 1.14 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| OPTN Daily Charts |
OPTN Intraday Charts |
Whats New @ Bazaartrend |
OPTN Free Analysis |
|
|
OPTN Important Levels Intraday
| RESISTANCE | 1.45 |
| RESISTANCE | 1.38 |
| RESISTANCE | 1.34 |
| RESISTANCE | 1.30 |
| SUPPORT | 1.18 |
| SUPPORT | 1.14 |
| SUPPORT | 1.10 |
| SUPPORT | 1.03 |
OPTN Forecast May 2024
| 4th UP Forecast | 3.55 |
| 3rd UP Forecast | 2.81 |
| 2nd UP Forecast | 2.35 |
| 1st UP Forecast | 1.89 |
| 1st DOWN Forecast | 0.59 |
| 2nd DOWN Forecast | 0.13 |
| 3rd DOWN Forecast | -0.33 |
| 4th DOWN Forecast | -1.07 |
OPTN Weekly Forecast
| 4th UP Forecast | 2.01 |
| 3rd UP Forecast | 1.76 |
| 2nd UP Forecast | 1.61 |
| 1st UP Forecast | 1.46 |
| 1st DOWN Forecast | 1.02 |
| 2nd DOWN Forecast | 0.87 |
| 3rd DOWN Forecast | 0.72 |
| 4th DOWN Forecast | 0.47 |
OPTN Forecast2024
| 4th UP Forecast | 7.46 |
| 3rd UP Forecast | 5.47 |
| 2nd UP Forecast | 4.23 |
| 1st UP Forecast | 3 |
| 1st DOWN Forecast | -0.52 |
| 2nd DOWN Forecast | -1.75 |
| 3rd DOWN Forecast | -2.99 |
| 4th DOWN Forecast | -4.98 |
OptiNose Inc ( NASDAQ USA Symbol : OPTN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OPTN Business Profile
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase 3b clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Address: 1020 Stony Hill Road, Yardley, PA, United States, 19067
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service